ITCH and neoplasm: Consistently, the results of treating a panel of breast, prostate, and bladder cancer cell lines showed that clomipramine, concomitant with ITCH suppressive activity, could also synergize with chemotherapeutics in killing tumor cells, supporting the role of ITCH-dependent autophagy in cancer progression (Rossi et al. 2014).